Whey Protein (Ma'aljobon) as a Complementary Therapy for Treatment of Attention-deficit/ Hyperactivity Disorder

Zeinab Mostajeran1, Seyed Hamdollah Mosavat2,3, Mostafa Najafi4

  • 1Department of Persian Medicine, School of Persian Medicine, Shahid Sadoughi University of Medical Sciences, Ardakan, Yazd, Iran.

Galen Medical Journal
|September 1, 2021
PubMed

Insights

Ma'aljobon, a whey protein, may help manage symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children. This study found it reduced hyperactivity and improved attention when used alongside standard treatment.

Area of Science:

  • Nutritional Neuroscience
  • Pediatric Psychiatry
  • Food Science

Background:

  • Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by hyperactivity, inattention, and impulsivity.
  • Ma'aljobon, a traditional whey protein product, is traditionally believed to offer immune modulation and potential neuropsychiatric benefits.

Purpose of the Study:

  • To investigate the efficacy of Ma'aljobon as a complementary therapy for managing ADHD symptoms in children.

Main Methods:

  • An 8-week open-label, randomized controlled trial involving 64 children diagnosed with ADHD.
  • Participants received either Ma'aljobon (25g daily) plus standard conventional treatment (SCT) or SCT alone.
  • Outcomes were assessed using the Strengths and Difficulties Questionnaire (SDQ) and Conners' Continuous Performance Test (CPT).

Main Results:

  • The intervention group showed a significant reduction in parent-reported hyperactivity scores on the SDQ (P=0.04).
  • Significant improvements in attention and focus were observed in the intervention group based on CPT results (P=0.01).
  • No significant differences were found in other SDQ scales between the groups.

Conclusions:

  • Ma'aljobon shows promise as an adjunctive treatment for enhancing hyperactivity control, attention, and focus in children with ADHD.
  • Further research with larger sample sizes and longer durations is recommended for more robust conclusions.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
441
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
174
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
399
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
459
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
25